SHINE Medical Technologies, Inc. (SHINE), a Wisconsin-based company dedicated to being the world leader in safe, clean, affordable production of medical isotopes, announced today that it has entered into a strategic long-term supply agreement with GE Healthcare, a division of the General Electric Company, for supply of molybdenum-99 (moly-99). This is the first announcement of a major supply agreement with a U.S. based producer of moly-99. Moly-99 decays into the diagnostic imaging agent technetium-99m (Tc-99m).  Tc‑99m’s extraordinary attributes make it the most commonly-used medical isotope on the planet (used in over 40 million medical imaging procedures per year). Under the terms of the supply agreement, SHINE will provide moly-99 to GE Healthcare on a regular basis once its facility becomes operational.

Read more here.